LON:VEC - Vectura Group Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: GBX 150
  • Forecasted Upside:
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 0
+0.30 (1.20%)

This chart shows the closing price for VEC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Vectura Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VEC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VEC

Analyst Price Target is GBX 150
▲ +∞ Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Vectura Group in the last 3 months. The average price target is GBX 150, with a high forecast of GBX 0 and a low forecast of GBX 0. The average price target represents a ∞ upside from the last price of GBX 0.

This chart shows the closing price for VEC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 2 polled investment analysts is to hold stock in Vectura Group. This rating has held steady since November 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/3/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/3/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/1/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
8/30/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
11/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
2/26/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/27/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/27/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/9/2021Peel HuntReiterated RatingHoldGBX 150
7/9/2021Peel HuntReiterated RatingHoldGBX 150
5/26/2021Shore CapitalReiterated RatingHold
5/26/2021Peel HuntReiterated RatingHoldGBX 122
5/26/2021Peel HuntReiterated RatingHoldGBX 122
7/30/2020Peel HuntBoost Price TargetBuyGBX 114 ➝ GBX 134
7/2/2020Peel HuntReiterated RatingBuy
6/3/2020Peel HuntReiterated RatingBuy
5/27/2020Shore CapitalReiterated RatingHold
5/27/2020Peel HuntReiterated RatingBuy
5/1/2020Peel HuntReiterated RatingBuy
4/24/2020Peel HuntReiterated RatingBuy
4/7/2020Peel HuntReiterated RatingBuy
3/23/2020JPMorgan Chase & Co.Lower Price TargetOverweightGBX 120 ➝ GBX 115
3/17/2020Shore CapitalReiterated RatingHold
3/17/2020Peel HuntReiterated RatingBuy
3/5/2020Peel HuntReiterated RatingBuy
2/5/2020Peel HuntReiterated RatingBuy
1/27/2020Peel HuntUpgradeBuy
1/10/2020Peel HuntReiterated RatingHold
1/6/2020JPMorgan Chase & Co.Boost Price TargetOverweightGBX 110 ➝ GBX 120
12/16/2019Peel HuntReiterated RatingHold
12/5/2019Peel HuntReiterated RatingHold
11/27/2019Shore CapitalReiterated RatingHold
11/27/2019Peel HuntReiterated RatingHold
11/7/2019CitigroupReiterated RatingBuy
11/4/2019Peel HuntReiterated RatingHold
10/29/2019Peel HuntReiterated RatingHold
9/24/2019Peel HuntLower Price TargetHoldGBX 119 ➝ GBX 114
9/11/2019CitigroupReiterated RatingBuy
9/10/2019Shore CapitalReiterated RatingHold
9/9/2019Peel HuntReiterated RatingHold
9/2/2019Peel HuntReiterated RatingHold
8/1/2019Peel HuntReiterated RatingHold
7/17/2019Shore CapitalReiterated RatingHold
7/17/2019Peel HuntReiterated RatingHold
7/3/2019Peel HuntReiterated RatingHold
6/10/2019Shore CapitalReiterated RatingHold
6/10/2019Peel HuntReiterated RatingHold
6/4/2019Peel HuntReiterated RatingHold
5/24/2019Morgan StanleyReiterated RatingBuyGBX 160
5/24/2019Peel HuntReiterated RatingHoldGBX 119
5/24/2019Shore CapitalReiterated RatingHold
5/24/2019Numis SecuritiesReiterated RatingBuy
5/9/2019Peel HuntBoost Price TargetHoldGBX 105 ➝ GBX 119
5/8/2019Numis SecuritiesReiterated RatingBuyGBX 160
5/8/2019Shore CapitalReiterated RatingHold
5/2/2019Peel HuntReiterated RatingHold
4/3/2019JPMorgan Chase & Co.Lower Price TargetOverweightGBX 110 ➝ GBX 100
4/2/2019Peel HuntReiterated RatingHold
3/26/2019Shore CapitalReiterated RatingHold
3/26/2019Peel HuntReiterated RatingHold
3/12/2019Peel HuntLower Price TargetHoldGBX 107 ➝ GBX 105
1/31/2019Peel HuntReiterated RatingHold
1/3/2019Numis SecuritiesInitiated CoverageBuyGBX 160
1/3/2019Peel HuntReiterated RatingHoldGBX 107
1/3/2019Shore CapitalReiterated RatingHold
1/2/2019JPMorgan Chase & Co.Lower Price TargetOverweightGBX 140 ➝ GBX 110
12/19/2018Peel HuntReiterated RatingHold
12/6/2018Peel HuntReiterated RatingHold
11/26/2018Numis SecuritiesReiterated RatingBuyGBX 160
11/26/2018Peel HuntReiterated RatingHold
11/26/2018Shore CapitalReiterated RatingHold
11/8/2018Peel HuntReiterated RatingHold
11/8/2018Shore CapitalReiterated RatingHold
10/31/2018Peel HuntReiterated RatingHold
10/23/2018Peel HuntReiterated RatingHold
10/3/2018Peel HuntLower Price TargetHoldGBX 111 ➝ GBX 107
9/12/2018Royal Bank of CanadaLower Price TargetSector PerformerGBX 92 ➝ GBX 88
9/12/2018Numis SecuritiesReiterated RatingBuy
9/12/2018JPMorgan Chase & Co.Reiterated RatingOverweight
9/11/2018Shore CapitalReiterated RatingHold
9/11/2018Peel HuntReiterated RatingHold
9/10/2018CitigroupReiterated RatingBuyGBX 155
9/4/2018Peel HuntReiterated RatingHold
8/23/2018Numis SecuritiesReiterated RatingBuy
8/21/2018JPMorgan Chase & Co.Reiterated RatingOverweightGBX 140
8/21/2018Peel HuntReiterated RatingHold
8/1/2018Peel HuntReiterated RatingHold
7/16/2018Shore CapitalLower Price TargetHoldGBX 105 ➝ GBX 78
7/3/2018Peel HuntReiterated RatingHold
5/31/2018Peel HuntReiterated RatingHold
5/17/2018Peel HuntReiterated RatingHold
4/20/2018Shore CapitalReiterated RatingHoldGBX 105
4/19/2018Peel HuntReiterated RatingHoldGBX 111
4/4/2018Peel HuntReiterated RatingHold
3/22/2018JPMorgan Chase & Co.Reiterated RatingOverweightGBX 140
3/22/2018Stifel NicolausReiterated RatingBuyGBX 151
3/22/2018Numis SecuritiesReiterated RatingBuyGBX 160
3/21/2018N+1 SingerReiterated RatingBuyGBX 120
3/21/2018Peel HuntReiterated RatingHoldGBX 120
3/21/2018Shore CapitalReiterated RatingHold
3/20/2018CitigroupReiterated RatingBuyGBX 155
3/13/2018JPMorgan Chase & Co.Reiterated RatingOverweightGBX 140
3/12/2018Numis SecuritiesReiterated RatingBuyGBX 170
3/12/2018Shore CapitalReiterated RatingHold
2/14/2018Peel HuntLower Price TargetHoldGBX 160 ➝ GBX 120
2/1/2018Peel HuntReiterated RatingHoldGBX 160
1/25/2018JPMorgan Chase & Co.Reiterated RatingOverweight
1/24/2018Peel HuntReiterated RatingHoldGBX 160
1/15/2018JPMorgan Chase & Co.Reiterated RatingOverweight
1/5/2018JPMorgan Chase & Co.Lower Price TargetOverweightGBX 170 ➝ GBX 140
1/4/2018Numis SecuritiesReiterated RatingBuyGBX 170
1/4/2018Peel HuntReiterated RatingHoldGBX 160
1/4/2018Shore CapitalReiterated RatingBuy
12/14/2017Royal Bank of CanadaUpgradeSector PerformerGBX 119
11/16/2017JPMorgan Chase & Co.Reiterated RatingOverweight
11/15/2017Peel HuntReiterated RatingHoldGBX 160
11/10/2017JPMorgan Chase & Co.Lower Price TargetOverweightGBX 180 ➝ GBX 175
11/9/2017Peel HuntReiterated RatingHoldGBX 160
11/9/2017Panmure GordonReiterated RatingBuyGBX 150
11/9/2017Numis SecuritiesLower Price TargetBuyGBX 205 ➝ GBX 170
11/9/2017Shore CapitalReiterated RatingBuy
10/31/2017Peel HuntReiterated RatingHoldGBX 160
10/5/2017Numis SecuritiesReiterated RatingBuyGBX 205
9/21/2017JPMorgan Chase & Co.Lower Price TargetOverweightGBX 210 ➝ GBX 180
9/18/2017CitigroupLower Price TargetBuyGBX 200 ➝ GBX 180
9/7/2017Numis SecuritiesReiterated RatingBuyGBX 205
9/6/2017Peel HuntReiterated RatingHoldGBX 160
8/30/2017Panmure GordonReiterated RatingBuy
8/16/2017Shore CapitalReiterated RatingBuy
8/16/2017Peel HuntReiterated RatingHoldGBX 160
6/29/2017Numis SecuritiesReiterated RatingBuyGBX 214
6/29/2017N+1 SingerReiterated RatingHold
6/29/2017Peel HuntReiterated RatingHoldGBX 160
6/16/2017Peel HuntReiterated RatingHoldGBX 160
(Data available from 5/28/2017 forward)

News Sentiment Rating

0.80 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/30/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/29/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/29/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/28/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/27/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/29/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/28/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/28/2022

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Vectura Group logo
Vectura Group plc engages in the design, development, and supply of pharmaceutical products for the treatment of airways-related diseases worldwide. The company's in-market products include Seebri, Breezhaler and Neohaler, a DPI device and bronchodilator; AirFluSal Forspiro for the treatment of asthma and chronic obstructive pulmonary disease (COPD); Breelib for the treatment of pulmonary arterial hypertension; Relvar Ellipta/Breo Ellipta that is used in treating asthma and COPD; and Incruse Ellipta, Anoro Ellipta, and Trelegy Ellipta for the treatment of COPD. It is also developing VR315 (US) for the treatment of asthma and COPD.In addition, the company offers dry powder inhalers, pressurized metered dose inhalers, and nebulized devices. Vectura Group plc was founded in 1997 and is headquartered in Chippenham, the United Kingdom.
Read More

Today's Range

Now: N/A

50 Day Range

MA: GBX 164.80
Low: 164.80
High: 164.80

52 Week Range

Now: N/A

Volume

203,761 shs

Average Volume

3,365,132 shs

Market Capitalization

£1.01 billion

P/E Ratio

8.20

Dividend Yield

23.06%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Vectura Group?

The following Wall Street analysts have issued research reports on Vectura Group in the last twelve months: Peel Hunt, and Peel Hunt LLP.
View the latest analyst ratings for VEC.

What is the current price target for Vectura Group?

0 Wall Street analysts have set twelve-month price targets for Vectura Group in the last year. Their average twelve-month price target is GBX 150.
View the latest price targets for VEC.

What is the current consensus analyst rating for Vectura Group?

Vectura Group currently has 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in VEC, but not buy more shares or sell existing shares.
View the latest ratings for VEC.

How do I contact Vectura Group's investor relations team?

Vectura Group's physical mailing address is One Prospect West, CHIPPENHAM, SN14 6FH, United Kingdom. The company's listed phone number is +44-1249-667700. The official website for Vectura Group is www.vectura.com. Learn More about contacing Vectura Group investor relations.